Thank you very much, Mr. Chair, and welcome, to our witnesses.
My first question is to Ms. McCready.
I'd like you to tell us how important clusters are in the biotech industry. In Winnipeg, for instance, when they built the level-four disease control laboratory, within months they had Biovail and all these small companies basically surrounding it. And it keeps growing. So perhaps tell me about the importance of clusters.
Secondly, there are two ways of doing things when it comes to research. One is to basically spread it across Canada, where everybody gets a little piece of the action. But what seem to be more prevalent now are centres of excellence, if you will. Maybe you could give me an idea, as well, of what you prefer when it comes to those two options.